StockNews.com Initiates Coverage on Titan Pharmaceuticals (NASDAQ:TTNP)
The Cerbat Gem -

StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance Titan Pharmaceuticals stock opened at $7.10 on Monday. The company has a 50 day moving average price of […]

In related news